The Largest Personal Injury Firm in Texas. Serving Clients Nationwide.
Corpus Christi 361-254-7873 San Antonio 210-874-2615 Nationwide Toll Free 866-517-5659
Contact us 24/7 Contact us 24/7

Fedratinib Clinical Trials

Brain Disorder in Fedratinib Drug Trial Patients

Thomas J. Henry is currently investigating reports of Wernicke’s encephalopathy in clinical drug trial patients being treated with Sanofi’s experimental cancer drug fedratinib.

ABOUT THE FEDRATINIB CLINICAL TRIALS

Fedratinib, also referred to as SAR302503, was being tested as a possible treatment for a number of different blood cancers including myelofibrosis, polycythemia vera, and essential thrombocythemia.

The U.S. Food and Drug Administration ordered that clinical trials for the drug be placed on a partial hold following reports that trial participants had experienced an increased risk of developing Wernicke’s encephalopathy, a brain disorder that can result in eye problems, confusion, loss of coordination, and memory loss.

However, when follow-up investigations conducted by the FDA and independent researchers determined that the risks posed by fedratinib outweighed its benefits, Sanofi scrapped the drug completely.

FEDRATINIB CLINICAL TRIAL LOCATIONS

Clinical trials for fedratinib were held in cities nationwide including:

HAVE YOU BEEN INJURED?

Contact Us for a FREE Case Review

866-517-5659 • info@tjhlaw.com

Loading...
Do you really want to end conversation?
chat-icon Live chat
avatar Waiting